MLH1 and head and neck squamous cell carcinoma: A study performed on cisplatin-resistant vs. cisplatin-sensitive HNSCC cell lines reported that the former had a significantly decreased expression of MLH1 compared to the latter [89], confirming previous evidence suggesting that a dysfunctional MMR is associated with a worse response to this type of chemotherapy [90,91].